NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

ABBV

Abbvie Inc

Apr 17 • 04:00PM ET

172.99

Dollar change +1.31
Percentage change 0.76	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: JNJ PFE MRK LLY BMY GILD AMGN REGN VRTX BIIB

| Held by: VTI VOO IVV SPY VTV SCHD XLV VIG VYM VHT

Scroll to Statements

Index	S&P 500	P/E	72.33	EPS (ttm)	2.39	Insider Own	0.11%	Shs Outstand	1.77B	Perf Week	-0.69%
Market Cap	306.02B	Forward P/E	12.43	EPS next Y	13.92	Insider Trans	-12.61%	Shs Float	1.77B	Perf Month	-18.50%
Income	4.24B	PEG	4.79	EPS next Q	2.37	Inst Own	73.36%	Short Float	0.97%	Perf Quarter	-0.41%
Sales	56.33B	P/S	5.43	EPS this Y	20.91%	Inst Trans	0.85%	Short Ratio	2.30	Perf Half Y	-9.84%
Book/sh	1.88	P/B	91.84	EPS next Y	13.74%	ROA	3.14%	Short Interest	17.14M	Perf Year	6.43%
Cash/sh	3.14	P/C	55.09	EPS next 5Y	15.11%	ROE	61.94%	52W Range	153.58 - 218.66	Perf YTD	-2.65%
Dividend Est.	6.51 (3.76%)	P/FCF	17.16	EPS past 5Y	-14.67%	ROI	6.58%	52W High	-20.89%	Beta	0.63
Dividend TTM	6.38 (3.69%)	Quick Ratio	0.55	Sales past 5Y	12.19%	Gross Margin	70.12%	52W Low	12.64%	ATR (14)	7.43
Dividend Ex-Date	Apr 15, 2025	Current Ratio	0.66	EPS Y/Y TTM	-12.14%	Oper. Margin	21.57%	RSI (14)	30.21	Volatility	3.05% 4.16%
Employees	55000	Debt/Eq	20.40	Sales Y/Y TTM	3.71%	Profit Margin	7.52%	Recom	1.89	Target Price	215.68
Option/Short	Yes / Yes	LT Debt/Eq	18.36	EPS Q/Q	-103.95%	Payout	263.15%	Rel Volume	1.14	Prev Close	171.68
Sales Surprise	1.82%	EPS Surprise	2.12%	Sales Q/Q	5.60%	Earnings	Apr 25 BMO	Avg Volume	7.44M	Price	172.99
SMA20	-9.70%	SMA50	-13.26%	SMA200	-7.98%	Trades		Volume	8,472,999	Change	0.76%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$191
Dec-05-24	Downgrade	Daiwa Securities	Outperform → Neutral	$180
Nov-22-24	Upgrade	Leerink Partners	Market Perform → Outperform	$206
Nov-15-24	Initiated	Wolfe Research	Outperform	$205
Nov-04-24	Upgrade	Argus	Hold → Buy
Oct-17-24	Initiated	Bernstein	Mkt Perform	$203
Jun-05-24	Upgrade	HSBC Securities	Hold → Buy	$185
May-17-24	Initiated	Cantor Fitzgerald	Overweight	$200
Jan-29-24	Upgrade	William Blair	Mkt Perform → Outperform
Dec-18-23	Downgrade	HSBC Securities	Buy → Hold
Dec-11-23	Upgrade	Goldman	Neutral → Buy
Nov-09-23	Initiated	Deutsche Bank	Hold	$150
Oct-30-23	Upgrade	Barclays	Equal Weight → Overweight	$160 → $170
Oct-20-23	Resumed	UBS	Neutral	$157 → $150
Sep-29-23	Initiated	Raymond James	Outperform	$177
Jul-25-23	Initiated	William Blair	Mkt Perform
Jul-14-23	Initiated	HSBC Securities	Buy	$167
Apr-05-23	Downgrade	Argus	Buy → Hold
Mar-01-23	Initiated	Guggenheim	Buy	$172
Feb-22-23	Downgrade	Wolfe Research	Outperform → Peer Perform

Show Previous Ratings

Today 01:02PM	Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights ABBV (GlobeNewswire)
10:02AM	Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits? (Insider Monkey)
10:00AM	AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-17-25 09:50AM	AbbVie Inc. (ABBV): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
08:10AM	My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys (Seeking Alpha)
05:51PM	Loading…
Apr-16-25 05:51PM	Neurocrine Biosciences: Recent Selloff Has Created A Potential Buying Opportunity (Seeking Alpha)
04:29PM	Analyst Report: AbbVie Inc. (Morningstar Research)
02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
11:20AM	AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now (Insider Monkey)
09:45AM	Top Cancer Stocks to Buy to Boost Your Portfolio's Health (Zacks)
05:06AM	Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks (StockStory)
04:33AM	The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment (Zacks)
Apr-15-25 04:30PM	Top Research Reports for AbbVie, TJX & Charles Schwab (Zacks)
10:43AM	Johnson & Johnson: First Look At Q1 Earnings - Solid Quarter Will Calm Nerves (Seeking Alpha)
07:45AM	AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In (Insider Monkey)
06:54AM	Loading…
06:54AM	The Zacks Analyst Blog Merck and AbbVie (Zacks)
06:20AM	Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now? (Zacks)
Apr-14-25 10:37AM	ABBV vs. MRK: Which Drug Giant is a Better Buy Now? (Zacks)
02:17AM	The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis (Zacks)
Apr-13-25 05:39PM	Is AbbVie Inc. (ABBV) the Best Stock for 15 Years? (Insider Monkey)
01:15PM	ClearBridge Appreciation ESG Strategy Q1 2025 Commentary (Seeking Alpha)
09:15AM	SCHD's Portfolio Shake-Up: What It Means For Investors (Rating Downgrade) (Seeking Alpha)
Apr-12-25 11:00AM	Goldman Sachs, J&J, To Report Earnings As Investors Watch Out For Retail Sales Data (Seeking Alpha)
01:27AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 13 (Seeking Alpha)
Apr-11-25 02:33PM	Final Trades: TJX, Meta, Abbvie and Taiwan Semi (CNBC TV)
12:45PM	IGD: Capital Erosion And Shrinking Dividend Payouts (Seeking Alpha)
11:47AM	Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More (Zacks)
10:16AM	Here's Why Clearbridge Growth Strategy Sold AbbVie (ABBV) (Insider Monkey)
06:20AM	Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now? (Zacks)
Apr-10-25 12:58PM	S&P, Dow Jones Pharma Names Rattled Again On Trump's Tariffs Whiplash (Investor's Business Daily)
09:44AM	Loading…
09:44AM	Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? (Zacks)
09:00AM	Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know (Zacks)
09:00AM	New York Plastic Surgical Group and Deep Blue Med Spa Receive State and National Recognition by Allergan Aesthetics (GlobeNewswire)
08:54AM	Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs (Zacks)
08:19AM	ClearBridge Growth Strategy Q1 2025 Commentary (Seeking Alpha)
07:00AM	3 Biopharmaceutical Stocks Bucking the Sell-Off (MarketBeat)
Apr-09-25 06:33PM	Analyst Report: AbbVie Inc. (Morningstar Research)
05:29PM	AbbVie: Thriving Beyond Humira's Patent Cliff (Upgrade) (Seeking Alpha)
10:06AM	Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan (Investor's Business Daily)
09:51AM	Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs (The Wall Street Journal)
07:00AM	2 Top Dividend Stocks That Could Set You Up for Life (Motley Fool)
06:20AM	Should You Invest in the SPDR S&P Biotech ETF (XBI)? (Zacks)
05:55AM	ClearBridge Appreciation Strategy Q1 2025 Commentary (Seeking Alpha)
05:01AM	AbbVies upadacitinib gains EU marketing authorisation for GCA (Pharmaceutical Technology)
Apr-08-25 09:15AM	AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis (Zacks) -5.83%
09:08AM	Goldman turns cautious on major pharma names, sees select upside at Eli Lilly (Investing.com)
06:20AM	Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar? (Zacks)
02:00AM	AbbVie Announces European Commission Approval of RINVOQ (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis (PR Newswire)
Apr-07-25 09:08AM	Syndax Pharmaceuticals: Down But Not Out (Seeking Alpha)
08:37AM	Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes (Zacks)
Apr-06-25 06:44AM	3 Dividend Stocks to Buy and Hold for the Next Decade (Motley Fool)
Apr-05-25 12:10PM	China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz (TipRanks)
08:30AM	2 Dividend Stocks to Buy Hand Over Fist in April (Motley Fool)
12:00AM	From Ray-Bans to Wigs, US Buyers May See Unexpected Price Hikes (Bloomberg)
Apr-03-25 05:45PM	AbbVie (ABBV) Stock Moves -1.73%: What You Should Know (Zacks) -7.28%
04:34PM	AbbVie cuts 2025 profit forecast on acquisition expenses (Reuters)
09:27AM	Analyst Report: AbbVie Inc. (Morningstar Research)
09:00AM	3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About (Motley Fool)
Apr-02-25 03:35PM	GSK: Under Threat From 'Double Whammy' Of Vaccine Skepticism And Pharma Tariffs (Seeking Alpha)
10:06AM	AbbVie Stock Rises 16% Year to Date: Time to Buy, Sell or Hold? (Zacks)
09:43AM	PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters (Zacks)
Apr-01-25 06:20AM	Should SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar? (Zacks)
Mar-31-25 04:07PM	Best Dividend Aristocrats For April 2025 (Seeking Alpha)
03:03PM	Sellas Life Sciences: A Hold For Now With Huge, But Uncertain, Near-Term Catalyst (Seeking Alpha)
10:20AM	AbbVie: Margin Expansion Potential Can Support Elevated P/E (Seeking Alpha)
09:45AM	PGIM Jennison Value Fund Q4 2024 Commentary (Seeking Alpha)
08:00AM	AbbVie to Host First-Quarter 2025 Earnings Conference Call (PR Newswire)
06:20AM	Should You Invest in the Vanguard Health Care ETF (VHT)? (Zacks)
04:53AM	Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades. (Motley Fool)
Mar-30-25 07:25PM	AbbVie Inc. (ABBV): Among the Best Dividend Aristocrat Stocks with Over 3% Yield (Insider Monkey)
05:00AM	Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors (Seeking Alpha)
Mar-29-25 07:33AM	MarketBeat Week in Review - 03/24 - 03/28 (MarketBeat)
06:45AM	3 Relatively Safe Stocks to Buy Right Now (Motley Fool)
12:06AM	PGIM Jennison Focused Value Fund Q4 2024 Commentary (Seeking Alpha)
Mar-28-25 06:20PM	Regulatory Condition Satisfied for License Agreement between AbbVie and Gubra (ACCESSWIRE)
01:37PM	Final Trades: PayPal, Meta, Abbvie and Snowflake (CNBC TV)
09:44AM	AbbVie Vs. Sanofi: Which Is The Better Investment Right Now (Seeking Alpha)
Mar-27-25 11:45PM	Putnam Large Cap Value Fund Q4 2024 Commentary (SeekingAlpha)
05:33PM	LENZ Therapeutics Stock Is Attractive Before PDUFA (SeekingAlpha)
09:00AM	AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:20AM	Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar? (Zacks)
03:01AM	CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... (GuruFocus.com)
Mar-26-25 12:31PM	5 Reasons To Buy Regenxbio Right Now (SeekingAlpha)
09:28AM	Merck & Co.: Looming Patent Expiries For Key Drugs Weakens Longer-Term Outlook (SeekingAlpha)
08:30AM	AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025 (PR Newswire)
08:00AM	The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors (Business Wire)
07:42AM	These Dividend Stocks Can Protect You From the Next Market Drop (Barrons.com)
06:30AM	2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income (Motley Fool)
Mar-25-25 05:11PM	S&P 500 Gains and Losses Today: International Paper Stock Pops on Upbeat Growth Outlook (Investopedia)
01:13PM	These Dividend Aristocrats Stocks Can Protect You From the Market Selloff (Barrons.com)
09:01AM	3 Healthcare Stocks in the Doghouse (StockStory)
06:47AM	5 Large Drug Stocks to Watch as Industry Recovers (Zacks)
06:20AM	Is SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now? (Zacks)
Mar-24-25 05:45PM	AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why (Zacks)
04:02AM	Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025 (PR Newswire)
Mar-23-25 01:55PM	Is AbbVie Inc. (ABBV) The Best Healthcare Dividend Stock to Invest in? (InsiderMonkey)
10:00AM	SCHD: Good Times Aren't Great (Rating Downgrade) (SeekingAlpha)
07:19AM	AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market (MarketBeat)
07:18AM	Wall Street Week Ahead (SeekingAlpha)
Mar-21-25 12:59PM	2025 Dividend Kings: Strong Run Continues (SeekingAlpha)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 31 '25	Option Exercise	79.02	25,700	2,030,814	112,066	Apr 02 05:00 PM
Stewart Jeffrey Ryan	EVP, CHIEF COMMERCIAL OFFICER	Mar 31 '25	Sale	210.08	58,832	12,359,504	53,234	Apr 02 05:00 PM
Stewart Jeffrey Ryan	Officer	Mar 31 '25	Proposed Sale	210.09	58,832	12,359,897		Mar 31 05:30 PM
Reents Scott T	EVP, CHIEF FINANCIAL OFFICER	Mar 14 '25	Sale	212.34	17,644	3,746,527	11,577	Mar 18 05:00 PM
Reents Scott T	Officer	Mar 14 '25	Proposed Sale	212.35	17,644	3,746,628		Mar 14 04:34 PM
GONZALEZ RICHARD A	Director	Feb 28 '25	Sale	205.11	92,460	18,964,471	395,097	Mar 04 05:00 PM
GONZALEZ RICHARD A	Director	Mar 03 '25	Sale	210.53	6,168	1,298,549	388,929	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Mar 03 '25	Option Exercise	159.88	18,008	2,879,040	22,627	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Mar 03 '25	Sale	210.00	18,008	3,781,680	4,619	Mar 04 05:00 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 28 '25	Sale	206.30	9,892	2,040,722	4,619	Mar 04 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Mar 03 '25	Sale	210.45	21,250	4,472,039	6,130	Mar 04 05:00 PM
GONZALEZ RICHARD A	Officer	Mar 03 '25	Proposed Sale	210.53	6,168	1,298,550		Mar 03 05:57 PM
PERRY C SIATIS	Officer	Mar 03 '25	Proposed Sale	210.00	18,008	3,781,680		Mar 03 04:28 PM
TIMOTHY RICHMOND	Officer	Mar 03 '25	Proposed Sale	210.46	21,250	4,472,184		Mar 03 04:08 PM
GONZALEZ RICHARD A	Officer	Feb 28 '25	Proposed Sale	205.11	92,460	18,964,882		Feb 28 05:37 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 26 '25	Option Exercise	98.48	16,260	1,601,313	28,906	Feb 28 05:00 PM
Buckbee Kevin K	SVP, CONTROLLER	Feb 26 '25	Sale	203.41	18,944	3,853,372	11,496	Feb 28 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Feb 26 '25	Option Exercise	114.36	22,210	2,539,936	66,494	Feb 28 05:00 PM
RICHMOND TIMOTHY J.	EVP, CHIEF HR OFFICER	Feb 26 '25	Sale	202.90	29,917	6,070,036	44,284	Feb 28 05:00 PM
PERRY C SIATIS	Officer	Feb 28 '25	Proposed Sale	206.31	9,892	2,040,790		Feb 28 04:12 PM
Buckbee Kevin K	Officer	Feb 26 '25	Proposed Sale	203.41	18,944	3,853,398		Feb 26 05:47 PM
TIMOTHY RICHMOND	Officer	Feb 26 '25	Proposed Sale	202.90	29,917	6,070,176		Feb 26 04:04 PM
Siatis Perry C	EVP, GC AND SECRETARY	Feb 20 '25	Sale	197.90	5,778	1,143,453	22,381	Feb 24 05:00 PM
PERRY C SIATIS	Officer	Feb 20 '25	Proposed Sale	197.90	5,778	1,143,492		Feb 20 04:10 PM
Buckbee Kevin K	SVP, CONTROLLER	Dec 16 '24	Option Exercise	93.50	1,800	168,300	8,783	Dec 18 05:00 PM
Buckbee Kevin K	SVP, CONTROLLER	Dec 16 '24	Sale	172.24	1,800	310,032	6,983	Dec 18 05:00 PM
Buckbee Kevin K	Officer	Dec 16 '24	Proposed Sale	172.25	1,800	310,045		Dec 16 05:34 PM
Hudson Thomas J	Officer	Aug 08 '24	Proposed Sale	189.08	49,170	9,297,210		Aug 08 05:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Aug 05 '24	Sale	186.52	66,500	12,403,580	446,599	Aug 07 05:00 PM
Hudson Thomas J	Officer	Aug 07 '24	Proposed Sale	187.62	101,886	19,115,380		Aug 07 04:22 PM
GONZALEZ RICHARD A	Officer	Aug 05 '24	Proposed Sale	187.36	66,500	12,459,360		Aug 05 10:54 AM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Option Exercise	77.49	282,845	21,919,048	795,944	Jul 19 04:40 PM
GONZALEZ RICHARD A	EXECUTIVE CHAIRMAN OF BOARD	Jul 17 '24	Sale	175.00	282,845	49,497,875	513,099	Jul 19 04:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABBV

Abbvie Inc

Upgrade your FINVIZ experience